Publication Topic

Haws LC, Walker NJ, DeVito MJ, Birnbaum LS, Unice KM, Scott PK, Harris MA, Farland WH, Finley BL, Staskal DF. Development of weighted distributions of REPs for dioxin-like compounds (DLCs). Society of Toxicology 46th Annual Meeting. March 25-29, Charlotte, NC, 2007.

Scott LLF, Harris M, Unice KM, Scott P, Nguyen LM, Haws LC, Paustenbach D. 2007. Effects of excluding Serum PCDD/F and dioxin-like PCB data of individuals with incomplete congener profiles on estimates of total TEQ. Ann Epidemiol. 17:732.

Scott P, Haws LC, Scott L, Harris M. Evaluation of background 2,3,7,8-PCDD/F congener profiles in human serum collected during NHANES 2001-2002 using principal components analysis. Dioxin 2007, Tokyo, Japan, September 2007.

Scott P, Haws LC, Scott L, Harris M. 2007. Evaluation of background dioxin-like PCB congener profiles in human serum collected during NHANES 2001-2002 using principal components analysis. Dioxin 2007, Tokyo, Japan, September 2007.

Ferriby LL, Williams ES, Lukesemburg WJ, Paustenbach DJ, Haws LC, Birnbaum LS, Harris M. Comparing PCDDs, PCDFs, and dioxin-like PCBs in farm-raised and wild-caught catfish from Southern Mississippi.  Dioxin 2006. Oslo, Norway, August 2006.

Haws LC, Su S, Harris MA, DeVito M, Walker N, Farland W, Finley B, Birnbaum L. 2006. Development of a refined database of mammalian relative potency estimates for dioxin-like compounds. Toxicol Sci. 89(1):4-30.

Ferriby LL, Franke K, Unice KM, Scott P, Haws LC, Harris M, Paustenbach DJ. Serum reference levels of PCDD/Fs and dioxin-like PCBs stratified by race/ethnicity, gender and age for the general U.S. population. American Public Health Association Annual Meeting and Exposition, Boston, MA, November 2006.

Haws LC, Scott PK, Unice KM, Gough M, Harris MA, Staskal DF, Paustenbach DJ, Pavuk M. Are dioxin body burdens surrogates for other risk factors in associations between dioxin and diabetes?  Dioxin 2006, Oslo, Norway, August 2006.

Haws LC, DeVito MJ, Birnbaum LS, Walker NJ, Scott PK, Unice KM, Harris MA, Farland WH, Finley BL, Staskal DF. An alternative method for establishing TEFs for dioxin-like compounds. Part 2. Development of an approach to quantitatively weight the underlying potency data. Dioxin 2006, Oslo, Norway, August 2006.

Paustenbach DJ, Harris M, Ferriby LL, Williams ES, Haws LC, Unice KM, Scott PK. Development of PCDD/F TEQ serum reference values for the U.S. population for use in evaluating biomonitoring results. Dioxin 2006, Oslo, Norway, August 2006.